Form 8-K - Current report:
SEC Accession No. 0001193125-16-725582
Filing Date
2016-09-29
Accepted
2016-09-29 15:30:04
Documents
7
Period of Report
2016-09-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d278290d8k.htm 8-K 12005
2 EX-99.1 d278290dex991.htm EX-99.1 24187
3 EX-99.2 d278290dex992.htm EX-99.2 3915
4 GRAPHIC g278290ex99_2s1g1.jpg GRAPHIC 260354
5 GRAPHIC g278290ex99_2s2g1.jpg GRAPHIC 416900
6 GRAPHIC g278290ex99_2s3g1.jpg GRAPHIC 243796
7 GRAPHIC g278290ex99_2s4g1.jpg GRAPHIC 215150
  Complete submission text file 0001193125-16-725582.txt   1607000
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-21898 | Film No.: 161909899
SIC: 2834 Pharmaceutical Preparations